Drawing for ONCOVASC-TERM

USPTO serial 79168704

ONCOVASC-TERM

Reviewed by CopyMark Law Group

Reg. 4975398Status 404
Filing date
Status date
Registration date
Jun 14, 2016
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOVASC-TERM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for medical purposes, namely, for tissue engineering and regenerative medicine; pharmaceutical and veterinary preparations for tissue engineering and regenerative medicine; sanitary preparations for medical purposes; food for babies; medical plasters, material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes, namely, for tissue engineering and regenerative medicine; biological preparations for veterinary purposes, namely, for tissue engineering and regenerative medicine; surgical implants comprised of living tissuesSECTION 71 - CANCELLED—
010Artificial limbs, eyes and teeth; suture materials; medical apparatus and instruments for use in tissue engineering and regenerative medicine; electrodes for medical use; diagnostic apparatus for medical purposes for tissue engineering and regenerative medicineSECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific research, analysis and testing in the field of tissue engineering and regenerative medicine and scientific research and design relating thereto; scientific and industrial research in the field of tissue engineering and regenerative medicine; Industrial analysis and scientific research in the field of tissue engineering and regenerative medicine; scientific testing services in the field of tissue engineering and regenerative medicine; scientific consultancy relating to tissue engineering and regenerative medicine; surveying; engineering services, namely, technical and scientific project planning in the field of tissue engineering and regenerative medicine; development of measuring and testing methods in the field of tissue engineering and regenerative medicine; material testing; quality control for others; research and development for others in the field of tissue engineering and regenerative medicine; architectural consultation; construction drafting; technical research in the field of tissue engineering and regenerative medicine; mechanical research; physics research; chemical research; engineering; chemistry services, namely, research in the field of chemistry; computer programming services; chemical analysis; architectural services; design and development of computer hardware and software; computer software installation and maintenance; website design services; research in the field of science and scientific research conducted using data bases and the internetSECTION 71 - CANCELLED—
044Medical services; veterinary services; medical analysis services relating to the treatment of persons provided by a medical laboratory, namely, for the purpose of tissue engineering and regenerative medicine; medical screening; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services, namely, agricultural adviceSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 30, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 30, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 16, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 16, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 16, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 30, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 30, 2022C71TCANCELLED SECTION 71—
Jun 14, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 12, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 29, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 29, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Sep 14, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 14, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 29, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 29, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2016GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 9, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 9, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 26, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 27, 2015CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 16, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 15, 2015RFNPREFUSAL PROCESSED BY IB—
Jul 28, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 28, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 27, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 26, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2015DOCKASSIGNED TO EXAMINER—
Jul 15, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance